Addex Therapeutics (ADXN) EV to FCF (2020 - 2026)

Addex Therapeutics has disclosed EV to FCF across 7 years of filings, most recently posting 4.53 for Q1 2026.

• In Q1 2026, EV to FCF fell 5.82% year-over-year to 4.53; the TTM figure through Mar 2026 stood at 1.51 (up 44.92% YoY), while the FY2025 annual figure was 0.22, down 10.77% from the prior year.
• EV to FCF came in at 4.53 for Q1 2026 at Addex Therapeutics, up from 6.26 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 0.61 in Q4 2024 to a low of 119.26 in Q1 2022.
• Average EV to FCF over 5 years is 18.55, with a median of 6.26 recorded in 2025.
• Year-over-year, EV to FCF soared 790.81% in 2024 and plunged 3182.57% in 2025.
• Over 5 years, EV to FCF stood at 5.14 in 2022, then surged by 101.32% to 0.07 in 2023, then soared by 790.81% to 0.61 in 2024, then plunged by 1133.05% to 6.26 in 2025, then increased by 27.62% to 4.53 in 2026.
• Per Business Quant data, the three most recent EV to FCF figures were 4.53 in Q1 2026, 6.26 in Q4 2025, and 7.48 in Q3 2025.